EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advances of therapy for Alzheimer's disease: An updated review

Can Mei, Jianbo Zhan, Shuzhen Zhu, Yutong Zhang, Chang‐e Xiong, Jia Wang, Yu Jia Xu, Hua Zhong, Jing Cheng

Brain‐X · 2024-09 · 2 (3)

DOI: 10.1002/brx2.68 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain‐X, online erschienen am 15.07.2024. Verfasst von Can Mei und 8 weiteren Autor:innen. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a type of dementia characterized by a decline in brain function, which leads to the inability to perform activities independently. Many researchers recognize abnormalities related to beta‐amyloid as the main cause of the disease (i.e., the beta‐amyloid hypothesis), but aging, genetics, coronary heart disease, environmental factors, gender, and other risk factors may also contribute to AD development. Three drugs with different mechanisms are available for AD treatment: cholinesterase inhibitors, N‐methyl d‐aspartate, and aducanumab. This study reviewed the therapies that are already applied in clinical practice and those that are currently being investigated for clinical use. These therapies include not only pharmacological treatments but also non‐pharmacological treatments, such as gut flora therapy and music therapy. A comprehensive understanding of these therapies is necessary to enable early intervention, improve patients' physical and mental conditions, delay the occurrence and development of AD, and extend patients' healthy lifespans.

Zitieren

APA

Mei, C., Zhan, J., Zhu, S., Zhang, Y., Xiong, C., Wang, J., Xu, Y. J., Zhong, H., & Cheng, J. (2024). Advances of therapy for Alzheimer's disease: An updated review. Brain‐X, 2(3). https://doi.org/10.1002/brx2.68

Vancouver

Mei C, Zhan J, Zhu S, Zhang Y, Xiong C, Wang J, et al. Advances of therapy for Alzheimer's disease: An updated review. Brain‐X. 2024;2(3). doi:10.1002/brx2.68

BibTeX
@article{Mei2024,
  author = {Mei, Can and Zhan, Jianbo and Zhu, Shuzhen and Zhang, Yutong and Xiong, Chang‐e and Wang, Jia and Xu, Yu Jia and Zhong, Hua and Cheng, Jing},
  title = {Advances of therapy for Alzheimer's disease: An updated review},
  journal = {Brain‐X},
  year = {2024},
  volume = {2},
  number = {3},
  doi = {10.1002/brx2.68}
}
Kostenlos starten →